1. Home
  2. TYRA vs NOG Comparison

TYRA vs NOG Comparison

Compare TYRA & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$27.56

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Northern Oil and Gas Inc.

NOG

Northern Oil and Gas Inc.

HOLD

Current Price

$25.83

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
NOG
Founded
2018
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
TYRA
NOG
Price
$27.56
$25.83
Analyst Decision
Strong Buy
Buy
Analyst Count
11
8
Target Price
$47.50
$31.14
AVG Volume (30 Days)
450.8K
2.2M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
6.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,475,723,000.00
Revenue This Year
N/A
$14.07
Revenue Next Year
N/A
$4.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.23
52 Week Low
$11.82
$17.18
52 Week High
$40.65
$31.17

Technical Indicators

Market Signals
Indicator
TYRA
NOG
Relative Strength Index (RSI) 53.53 60.09
Support Level $27.40 $25.43
Resistance Level $33.35 $28.81
Average True Range (ATR) 1.34 0.76
MACD 0.39 -0.20
Stochastic Oscillator 66.51 25.38

Price Performance

Historical Comparison
TYRA
NOG

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

Share on Social Networks: